151 related articles for article (PubMed ID: 37394225)
1. Retrospective analysis of serum free light chain reference intervals and risk for monoclonal gammopathy suggests different limits than those in international guidelines.
Schroeder LF; Manthei DM; Keren DF
Clin Biochem; 2023 Aug; 118():110604. PubMed ID: 37394225
[TBL] [Abstract][Full Text] [Related]
2. [Usefulness of a free light chain immunoassay in serum for the diagnosis and the follow-up of monoclonal gammopathy].
Guenet L; Decaux O; Lechartier H; Ropert M; Grosbois B
Rev Med Interne; 2007 Oct; 28(10):689-97. PubMed ID: 17566612
[TBL] [Abstract][Full Text] [Related]
3. [The value of serum free light chain in differential diagnosis of monoclonal gammopathy of renal significance].
Li C; Wen YB; Li H; Su W; Li J; Cai JF; Chen LM; Li XM; Li XW
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(30):2344-2348. PubMed ID: 28822451
[No Abstract] [Full Text] [Related]
4. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
[TBL] [Abstract][Full Text] [Related]
5. Serum free light chain reference intervals in an Optilite and their influence on clinical guidelines.
Morales-García LJ; Pacheco-Delgado MS
Clin Biochem; 2021 Jun; 92():54-60. PubMed ID: 33662349
[TBL] [Abstract][Full Text] [Related]
6. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.
Katzmann JA; Clark RJ; Abraham RS; Bryant S; Lymp JF; Bradwell AR; Kyle RA
Clin Chem; 2002 Sep; 48(9):1437-44. PubMed ID: 12194920
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
[TBL] [Abstract][Full Text] [Related]
8. Data analytics improves the diagnostic accuracy of serum free light chain results for detecting monoclonal gammopathy.
Treger RS; Mathias PC; Cowan AJ; Green D; Hutchinson K; Bryan A; Chaudhary A; Fink SL; Wener MH; Morishima C
Am J Clin Pathol; 2024 Mar; 161(3):216-231. PubMed ID: 37936261
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of quantitative kappa and lambda free light chain assays in clinical practice.
Katzmann JA; Abraham RS; Dispenzieri A; Lust JA; Kyle RA
Clin Chem; 2005 May; 51(5):878-81. PubMed ID: 15774572
[TBL] [Abstract][Full Text] [Related]
10. Kappa Free Light Chain Drift Prompts the Need for a New Upper Limit of Normal Free Light Chain Ratio to Avoid an Epidemic of Kappa Light Chain Monoclonal Gammopathy of Undermined Significance.
Rozenova K; Willrich M; Snyder M; Dasari S; Kourelis T; Rajkumar SV; Kumar S; Dispenzieri A; Murray DL
J Appl Lab Med; 2023 Jul; 8(4):742-750. PubMed ID: 37232112
[TBL] [Abstract][Full Text] [Related]
11. Light Chain Predominant Intact Immunoglobulin Monoclonal Gammopathy Disorders: Shorter Survival in Light Chain Predominant Multiple Myelomas.
Singh G; Xu H
Lab Med; 2021 Jul; 52(4):390-398. PubMed ID: 33180138
[TBL] [Abstract][Full Text] [Related]
12. A review of clinical guidelines, laboratory recommendations and external quality assurance programs for monoclonal gammopathy testing.
Lim SM; Wijeratne N; Choy KW; Nguyen TTH; Setiawan L; Loh TP
Crit Rev Clin Lab Sci; 2024 Mar; 61(2):107-126. PubMed ID: 37776896
[TBL] [Abstract][Full Text] [Related]
13. [Usefulness of free light chain measurement in monoclonal gammopathy, other haematological malignancies and autoimmune diseases].
Verebi C; Talbot A; Gendron N; Hurtado-Nedelec M
Ann Biol Clin (Paris); 2019 Aug; 77(4):397-406. PubMed ID: 31418701
[TBL] [Abstract][Full Text] [Related]
14. Reference change values of M-protein, free light chain and immunoglobulins in monoclonal gammopathy.
Evliyaoglu O; van Helden J; Jaruschewski S; Imöhl M; Weiskirchen R
Clin Biochem; 2019 Dec; 74():42-46. PubMed ID: 31526775
[TBL] [Abstract][Full Text] [Related]
15. [Diagnostic accuracy of serum protein electrophoresis and free light chain measurements for monoclonal gammopathies].
Peña C; Ortiz M; Voisin J; Peralta A; Balboa V; Delgado F
Rev Med Chil; 2018 Jan; 146(1):64-67. PubMed ID: 29806679
[TBL] [Abstract][Full Text] [Related]
16. A rare case of IgE kappa monoclonal gammopathy of undetermined significance identified in a Swedish female.
Fager Ferrari M; Lemonakis K; Förnvik Jonsson M
Scand J Clin Lab Invest; 2021 Sep; 81(5):385-388. PubMed ID: 34097568
[TBL] [Abstract][Full Text] [Related]
17. Use of the Current Standard of Practice Serum Free Light Chains (sFLC) Reference Interval Puts Black Patients at 5 Times Higher Odds for Light Chain Monoclonal Gammopathy of Undetermined Significance (LC-MGUS).
Azimi V; Fiala MA; Zaydman MA
Clin Chem; 2023 Sep; 69(9):1084-1086. PubMed ID: 37366327
[No Abstract] [Full Text] [Related]
18. Inter-assay variability in automated serum free light chain assays and their use in the clinical laboratory.
Caponi L; Romiti N; Koni E; Fiore AD; Paolicchi A; Franzini M
Crit Rev Clin Lab Sci; 2020 Mar; 57(2):73-85. PubMed ID: 31612753
[TBL] [Abstract][Full Text] [Related]
19. Practical considerations for the measurement of free light chains in serum.
Tate JR; Gill D; Cobcroft R; Hickman PE
Clin Chem; 2003 Aug; 49(8):1252-7. PubMed ID: 12881439
[TBL] [Abstract][Full Text] [Related]
20. [Monoclonal gammopathy of (un)known significance].
Steinhardt M; Kortüm M; Einsele H; Rasche L
Dtsch Med Wochenschr; 2022 Jun; 147(11):675-682. PubMed ID: 35636418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
